| Authors: |
Thege FI; Division of Surgical Oncology, Department of Surgery, The Ohio State University Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: fredrik.thege@osumc.edu., Hoskins A; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kramer A; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Salim I; Klinik und Poliklinik für Innere Medizin II, TUM University Hospital, Munich, Germany., Seetharaman A; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fowlkes N; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rajapakshe KI; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maitra A; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA., Wörmann SM; Klinik und Poliklinik für Innere Medizin II, TUM University Hospital, Munich, Germany. Electronic address: sonja.woermann@tum.de. |
